Sign In
Buy CNS
$70.20
-1.00 (-1.40%)
At Close: Jun 03, 2026
Cohen & Steers REIT and Preferred and Income Fund, Inc. (RNP) Notification of Sources of Distribution Under Section 19(a)
06:20pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers REIT and Preferred and Income Fund, Inc. (NYSE: RNP) (the "Fund") with information regarding the sou
Cohen & Steers Total Return Realty Fund, Inc. (RFI) Notification of Sources of Distribution Under Section 19(a)
06:19pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) (the "Fund") with information regarding the sources of th
Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)
05:43pm, Thursday, 27'th Feb 2025
NEW YORK , Feb. 27, 2025 /PRNewswire/ -- This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the "Fund") with information regarding the sources of
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
09:05am, Wednesday, 26'th Feb 2025
Cash on hand provides over one year of runway to fund expected operations HOUSTON, TX / ACCESS Newswire / February 26, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopha
Corero Network Security Strengthens Latin America Presence with Key Win and Growing Partner Network
07:00am, Tuesday, 25'th Feb 2025
MARLBOROUGH, Mass. , Feb. 25, 2025 /PRNewswire/ -- As part of its strategic expansion in Latin America, Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service (DDoS) pro
Cohen & Steers, Inc. Declares Quarterly Dividend
04:23pm, Thursday, 20'th Feb 2025
NEW YORK , Feb. 20, 2025 /PRNewswire/ -- The Board of Directors of Cohen & Steers, Inc. (NYSE: CNS) declared a cash dividend for the first quarter of 2025 in the amount of $0.62 per share of common s
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
09:00am, Thursday, 20'th Feb 2025
Webcast presentation Wednesday, February 26th at 3:20 PM CET HOUSTON, TX / ACCESS Newswire / February 20, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical c
Trumpflation Positions Cohen & Steers Poorly Due To Real Estate And Preferred Focus
05:50pm, Wednesday, 19'th Feb 2025
Cohen & Steers (CNS) faces AUM declines due to asset depreciation in REITs and preferred shares amid persistent inflation affecting bond markets. This could be a portent for incoming outflows or inflo
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
09:00am, Wednesday, 19'th Feb 2025
On-demand video webcast now available here HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializin
CNS Pharmaceuticals Announces Reverse Stock Split
08:30am, Wednesday, 19'th Feb 2025
HOUSTON, TX / ACCESS Newswire / February 19, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments fo
CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit
09:00am, Tuesday, 18'th Feb 2025
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments fo
Cohen & Steers Announces Changes to Realty Indexes
04:05pm, Friday, 14'th Feb 2025
NEW YORK , Feb. 14, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today pending changes to its Global Realty Majors Portfolio Index (GRM) and International Realty Majors Portfolio In
LG CNS Joins SAP Regional Strategic Services Partner Initiative in Asia Pacific
07:00am, Friday, 14'th Feb 2025
Extending expertise in ERP consulting•implementation•operations across the region Driving client business innovation by integrating AI and cloud advancements into SAP's latest Cloud ERP solutio
Cohen & Steers Strengthens ETF Leadership with Griffin Frank and Alexander Berg
09:00am, Tuesday, 11'th Feb 2025
NEW YORK , Feb. 11, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) is introducing Griffin Frank as Head of ETF Capital Markets and Alexander Berg as Head of ETF Sales, underscoring the firm's s
CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
08:00am, Monday, 10'th Feb 2025
In-person presentation today, February 10th at 1:15 PM ET HOUSTON, TX / ACCESS Newswire / February 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical c
